{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Affinito A"],"funding":["H2020-MSCA-RISE-2019","PNRR-MUR NextGenerationEU"],"pagination":["768"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12190191"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["15(6)"],"pubmed_abstract":["Glioblastoma (GBM) is the most aggressive and challenging brain cancer, in terms of diagnosis and therapy. The highly infiltrative glioblastoma stem cells (GSCs) are difficult to visualize and surgically remove with the current diagnostic tools, which often lead to misdiagnosis and false-positive results. In this study, we focused on a groundbreaking tool for specifically visualizing and removing GSCs. We exploited the specific binding of A40s aptamer to EphA2 for the selective delivery of Near-Infrared Dyes (NIR-Dyes), like IR700DX and ICG, both in vitro and in vivo. The A40s aptamer, engineered through the NIR-Dye conjugation, did not affect aptamer binding ability; indeed, A40s-NIR-Dye conjugates bound GLI261 stem-like cells and patient-derived GSCs in vitro; moreover, they induced cell"],"journal":["Biomolecules"],"pubmed_title":["Targeting Glioblastoma Stem Cells: A40s Aptamer-NIR-Dye Conjugate for Glioblastoma Visualization and Treatment."],"pmcid":["PMC12190191"],"funding_grant_id":["PRISAR2 872860","CN00000041- CUP E63C22000940007"],"pubmed_authors":["Ingenito F","Musella E","Condorelli G","Mascolo M","Mezzanotte L","Verde S","Fiore D","Pignataro C","Pattanayak B","Petrillo G","De Luca G","Quintavalle C","Affinito A","Fraticelli A"],"additional_accession":[]},"is_claimable":false,"name":"Targeting Glioblastoma Stem Cells: A40s Aptamer-NIR-Dye Conjugate for Glioblastoma Visualization and Treatment.","description":"Glioblastoma (GBM) is the most aggressive and challenging brain cancer, in terms of diagnosis and therapy. The highly infiltrative glioblastoma stem cells (GSCs) are difficult to visualize and surgically remove with the current diagnostic tools, which often lead to misdiagnosis and false-positive results. In this study, we focused on a groundbreaking tool for specifically visualizing and removing GSCs. We exploited the specific binding of A40s aptamer to EphA2 for the selective delivery of Near-Infrared Dyes (NIR-Dyes), like IR700DX and ICG, both in vitro and in vivo. The A40s aptamer, engineered through the NIR-Dye conjugation, did not affect aptamer binding ability; indeed, A40s-NIR-Dye conjugates bound GLI261 stem-like cells and patient-derived GSCs in vitro; moreover, they induced cell","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 May","modification":"2026-04-08T19:35:04.366Z","creation":"2026-04-08T14:00:53.984Z"},"accession":"S-EPMC12190191","cross_references":{"pubmed":["40563410"],"doi":["10.3390/biom15060768"]}}